Who we are

According to the most recent studies, people with hereditary neuropathy due to mutation of MFN2 (CMT2A, both in its classical form and in its clinical variants ) should be about 20% of people with Charcot-Marie-Tooth disease type 2, equal to a few thousand people in Europe and the USA.

However, very few cases are diagnosed and patients are not in contact with each other, nor is there a national register of these patients.

We want to:

  • seek, know and connect patients
  • act as a “bridge” between patients and scientific research
  • offer links to the most important publications, indicate the name and address of the research sites and research centres
  • create and update a scientific database
  • promote and encourage the formation of groups, associations, medical scientific projects

Visit us on www.progettomitofusina2.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Join our mailing list. Always stay up to date.